ArticleCancers2026

In-Treatment Kinetics of Peripheral Blood Immune Markers in PD-L1 High Non-Small Cell Lung Cancer and Prognostic Relevance for Immunotherapy Outcomes.

Ioannis P Trontzas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.